Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Back pain injection may quietly thin Bones—Study investigates

NCT ID NCT00941473

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This study asks whether epidural steroid injections, commonly used for back pain, can reduce bone density in postmenopausal women. Researchers will track bone turnover markers and bone mineral density in women aged 55–80 over a year after a single injection. The goal is to see if these injections might increase fracture risk and whether preventive steps are needed.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Epidural steroid injection of 80 mg triamcinolone (Kenalog)
What this could lead to
If this trial shows a link, it could lead to better counseling and preventive measures for postmenopausal women receiving epidural steroid injections for back pain.
What could go wrong
This is a small, early study with only 28 participants, so results may not apply to all women. Also, the study only observes changes, not whether they cause fractures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

28 people

The number who actually took part.

Start date

Jul 2007

Finished

Jul 2011

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants were recruited from an orthopedic spine clinic within a large metropolitan health system.

Ages

55 to 80 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients with low back pain and have consented to ESI. Age 55 and 5 years postmenopausal Caucasian women. Exclusion Criteria: 1. any women who doesn't meet the inclusion criteria 2. Women with history of a disease affection bone turnover 3. Women taking any drugs known to influence bone metabolism 4. Women who had smoked within the preceding year 5. Women with abnormal serum thyrotropin concentration, or high parathyroid hormone concentratons. 6. Women who had received more than two short courses (lasting 2 weeks or less) of oral or parenteral glucocorticoids in the preceding year or any oral or pareneteral or local (intraarticular, paraspinal,...) or inhaled glucocorticoids in the preceding year 7. Women diagnosed with osteoporosis (T score\<=2.5) on baseline DXA or had history of osteoportic fracture. 8. Pregnant women 9. Severe scoliosis -

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for To assess the changes in bone mineral density are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Henry Ford Hospital W. Bloomfield

    West Bloomfield, Michigan, 48322, United States